Adriamycin and Ifosfamide Combined With Sintilimab
Status:
Not yet recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
The aim of this study was to explore the efficacy and safety of adriamycin and ifosfamide
combined with sintilimab in the treatment of advanced or unresectable soft tissue sarcoma.